Paramount Bed Holdings Co., Ltd.

TSE:7817 Stock Report

Market Cap: JP¥145.7b

Paramount Bed Holdings Valuation

Is 7817 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7817 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7817 (¥2530) is trading below our estimate of fair value (¥4041.66)

Significantly Below Fair Value: 7817 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7817?

Key metric: As 7817 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7817. This is calculated by dividing 7817's market cap by their current earnings.
What is 7817's PE Ratio?
PE Ratio19.2x
EarningsJP¥7.60b
Market CapJP¥145.72b

Price to Earnings Ratio vs Peers

How does 7817's PE Ratio compare to its peers?

The above table shows the PE ratio for 7817 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21x
6960 Fukuda Denshi
12.6x5.6%JP¥208.4b
7716 Nakanishi
22.2x10.4%JP¥193.1b
7575 Japan Lifeline
11.3x6.8%JP¥89.7b
6849 Nihon Kohden
37.8x20.3%JP¥358.9b
7817 Paramount Bed Holdings
19.2x15.4%JP¥145.7b

Price-To-Earnings vs Peers: 7817 is good value based on its Price-To-Earnings Ratio (19.2x) compared to the peer average (21x).

Price to Earnings Ratio vs Industry

How does 7817's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
7817 19.2xIndustry Avg. 15.6xNo. of Companies6PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7817 is expensive based on its Price-To-Earnings Ratio (19.2x) compared to the JP Medical Equipment industry average (15.6x).

Price to Earnings Ratio vs Fair Ratio

What is 7817's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7817 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.2x
Fair PE Ratio20.7x

Price-To-Earnings vs Fair Ratio: 7817 is good value based on its Price-To-Earnings Ratio (19.2x) compared to the estimated Fair Price-To-Earnings Ratio (20.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7817 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,530.00
JP¥2,950.00
+16.6%
5.1%JP¥3,100.00JP¥2,800.00n/a2
Nov ’25JP¥2,616.00
JP¥2,950.00
+12.8%
5.1%JP¥3,100.00JP¥2,800.00n/a2
Oct ’25JP¥2,607.00
JP¥2,950.00
+13.2%
5.1%JP¥3,100.00JP¥2,800.00n/a2
Sep ’25JP¥2,585.00
JP¥2,950.00
+14.1%
5.1%JP¥3,100.00JP¥2,800.00n/a2
Aug ’25JP¥2,482.00
JP¥3,000.00
+20.9%
3.3%JP¥3,100.00JP¥2,900.00n/a2
Jul ’25JP¥2,671.00
JP¥3,000.00
+12.3%
3.3%JP¥3,100.00JP¥2,900.00n/a2
Jun ’25JP¥2,667.00
JP¥2,900.00
+8.7%
6.9%JP¥3,100.00JP¥2,700.00n/a2
May ’25JP¥2,663.00
JP¥3,000.00
+12.7%
10.0%JP¥3,300.00JP¥2,700.00n/a2
Apr ’25JP¥2,613.00
JP¥3,000.00
+14.8%
10.0%JP¥3,300.00JP¥2,700.00n/a2
Mar ’25JP¥2,498.00
JP¥3,000.00
+20.1%
10.0%JP¥3,300.00JP¥2,700.00n/a2
Feb ’25JP¥2,677.00
JP¥3,075.00
+14.9%
7.3%JP¥3,300.00JP¥2,850.00n/a2
Jan ’25JP¥2,771.00
JP¥3,075.00
+11.0%
7.3%JP¥3,300.00JP¥2,850.00n/a2
Dec ’24JP¥2,726.00
JP¥3,075.00
+12.8%
7.3%JP¥3,300.00JP¥2,850.00n/a2
Nov ’24JP¥2,546.00
JP¥2,700.00
+6.0%
11.1%JP¥3,000.00JP¥2,400.00JP¥2,616.002
Oct ’24JP¥2,355.00
JP¥2,700.00
+14.6%
11.1%JP¥3,000.00JP¥2,400.00JP¥2,607.002
Sep ’24JP¥2,377.00
JP¥2,700.00
+13.6%
11.1%JP¥3,000.00JP¥2,400.00JP¥2,585.002
Aug ’24JP¥2,308.00
JP¥2,700.00
+17.0%
11.1%JP¥3,000.00JP¥2,400.00JP¥2,482.002
Jul ’24JP¥2,391.00
JP¥2,850.00
+19.2%
5.3%JP¥3,000.00JP¥2,700.00JP¥2,671.002
Jun ’24JP¥2,312.00
JP¥2,900.00
+25.4%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,667.002
May ’24JP¥2,429.00
JP¥2,900.00
+19.4%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,663.002
Apr ’24JP¥2,358.00
JP¥2,900.00
+23.0%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,613.002
Mar ’24JP¥2,372.00
JP¥2,900.00
+22.3%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,498.002
Feb ’24JP¥2,472.00
JP¥2,900.00
+17.3%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,677.002
Jan ’24JP¥2,578.00
JP¥2,900.00
+12.5%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,771.002
Dec ’23JP¥2,704.00
JP¥2,900.00
+7.2%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,726.002
Nov ’23JP¥2,463.00
JP¥2,900.00
+17.7%
6.9%JP¥3,100.00JP¥2,700.00JP¥2,546.002

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

FINDEX

JP¥20.5b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

7D

-0.7%

1Y

-12.5%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,936.00

7D

-2.8%

1Y

-1.8%

Saint-Care Holding

JP¥18.1b

Provides healthcare services in Japan.

2374

JP¥735.00

7D

2.8%

1Y

-21.4%